The estimated Net Worth of Frederic J Winssinger is at least $797 Tysiąc dollars as of 2 August 2024. Mr. Winssinger owns over 674 units of Usana Health Sciences Inc stock worth over $143,453 and over the last 8 years he sold USNA stock worth over $438,376. In addition, he makes $214,871 as Independent Director at Usana Health Sciences Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Winssinger USNA stock SEC Form 4 insiders trading
Frederic has made over 25 trades of the Usana Health Sciences Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 674 units of USNA stock worth $25,127 on 2 August 2024.
The largest trade he's ever made was selling 2,000 units of Usana Health Sciences Inc stock on 27 April 2023 worth over $134,500. On average, Frederic trades about 383 units every 60 days since 2017. As of 2 August 2024 he still owns at least 3,848 units of Usana Health Sciences Inc stock.
You can see the complete history of Mr. Winssinger stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Frederic Winssinger biography
Frederic J. Winssinger is Independent Director of USANA Health Sciences, Inc. Compensation Committee Chair, Audit Committee and Governance, Risk & Nominating Committee member. Mr. Winssinger became a director in May 2016. Mr. Winssinger has been a Managing Partner of RW Partners LLC (RWP) since 2006. RWP is a commercial real estate private equity investment company based in Phoenix, Arizona. Mr. Winssinger also oversees his family's general investment operations and in 2014, he co-founded PlanninCore Wealth Advisors to provide investment advice to individuals and families. Prior to 2006, Mr. Winssinger worked in strategy consulting for the Boston Consulting Group and as a Portfolio Manager/Financial Analyst for JP Morgan Asset Management and other privately held asset management companies. Mr. Winssinger received a B.A. in Mathematics and Economics from Claremont McKenna College and an M.B.A from The Wharton School of the University of Pennsylvania. Mr. Winssinger's qualifications to sit on our Board include his 20 years of experience in financial analysis, and his training in evaluating corporate strategy towards the creation of shareholder value under sound corporate governance.
What is the salary of Frederic Winssinger?
As the Independent Director of Usana Health Sciences Inc, the total compensation of Frederic Winssinger at Usana Health Sciences Inc is $214,871. There are 15 executives at Usana Health Sciences Inc getting paid more, with Kevin Guest having the highest compensation of $4,157,830.
How old is Frederic Winssinger?
Frederic Winssinger is 52, he's been the Independent Director of Usana Health Sciences Inc since 2016. There are 14 older and 8 younger executives at Usana Health Sciences Inc. The oldest executive at Usana Health Sciences Inc is Dr. Myron W. Wentz, 80, who is the Founder & Chairman Emeritus.
What's Frederic Winssinger's mailing address?
Frederic's mailing address filed with the SEC is 2944 N 44TH STREET, SUITE 250, PHOENIX, AZ, 85018.
Insiders trading at Usana Health Sciences Inc
Over the last 28 years, insiders at Usana Health Sciences Inc have traded over $838,318,381 worth of Usana Health Sciences Inc stock and bought 4,600 units worth $120,973 . The most active insiders traders include Myron W Wentz, Global Ltd Gull oraz Myron W Gull Global Ltd Wentz. On average, Usana Health Sciences Inc executives and independent directors trade stock every 7 days with the average trade being worth of $572,994. The most recent stock trade was executed by Paul A. Jones on 13 August 2024, trading 6,266 units of USNA stock currently worth $240,489.
What does Usana Health Sciences Inc do?
usana health sciences’ mission is to develop and provide the highest quality, science-based health products, distributed internationally through network marketing, creating a rewarding financial opportunity for our independent associates, shareholders, and employees. we’ve got history. not baggage. we’ve been around since 1992, so we’re experienced (we’ve heard that’s a plus). and we look great for our age. plus, we have substance to go along with our great looks. we’ve got top-notch manufacturing facilities, our own scientists and research and development team, and the highest standards for our nutritional products. we have an award-winning compensation plan and award-winning products. we don’t like to brag, but we come pretty highly recommended. that’s because we got off on the right foot. we were founded by a scientist—not a corporate suit. usana’s founder, myron wentz, is an internationally recognized microbiologist, immunologist, and pioneer in infectious disease diagnosis. but su
What does Usana Health Sciences Inc's logo look like?
Complete history of Mr. Winssinger stock trades at Usana Health Sciences Inc
Usana Health Sciences Inc executives and stock owners
Usana Health Sciences Inc executives and other stock owners filed with the SEC include:
-
Kevin Guest,
Chairman of the Board, Chief Executive Officer -
Jim Brown,
President -
Kevin G. Guest,
Chairman & CEO -
G Hekking,
Chief Financial Officer -
David Mulham,
Chief Field Development Officer -
Walter Noot,
Chief Operating Officer -
Jim Brown,
Pres -
Daniel Macuga,
Chief Communications and Marketing Officer -
G. Douglas Hekking,
Chief Financial Officer -
David Mulham,
Chief Sales Officer -
Walter Noot,
Chief Operating Officer -
Paul Jones,
Chief Leadership Development Officer -
Peggie Pelosi,
Independent Director -
Gilbert Fuller,
Lead Independent Director -
Robert Anciaux,
Senior Director -
Frederic Winssinger,
Independent Director -
Feng Peng,
Independent Director -
Timothy Wood,
Independent Director -
Dr. Myron W. Wentz,
Founder & Chairman Emeritus -
John Fleming,
Director -
Brent Neidig,
Chief Officer and Managing Director of China -
P. Joshua Foukas,
Chief Legal Officer, General Counsel and Corporate Secretary -
Robert Sinnott,
Chief Scientific Officer -
P. Joshua Foukas,
Chief Legal Officer, Gen. Counsel & Corp. Sec. -
Patrique Richards,
Exec. Director of Investor Relations & Bus. Devel. -
Dr. John Cuomo,
Exec. Director of Product Devel. & Technology -
J Scott Nixon,
Director -
Myron W Gull Global Ltd Wentz,
-
Robert Auciaux,
-
Global Ltd Gull,
10% owner -
Myron W Wentz,
CEO -
Deborah Woo,
E.V.P. of Sales -
Donald R. Williams,
Director -
Dave Wentz,
President -
James Bramble,
-
Jerry G Mcclain,
Director -
Denis E Waitley,
Director -
Roy Truett,
Chief Information Officer -
Doug Braun,
Chief Marketing Officer -
Ronald S Poelman,
Director -
Rick Stambaugh,
Chief Information Officer -
Holdings Ltd Gull,
10% owner -
Fred W Cooper,
Vice President of Operations -
Jeffrey Yates,
Chief Financial Officer -
Mark H Wilson,
V.P. of Customer Relations -
Bradford Richardson,
E.V.P. of Asia Pacific -
G Doug Iiekking,
CHIEF FINANCIAL OFFICER -
Peter Benedict,
CHIEF INFORMATION OFFICER -
Joshua Foukas,
CHIEF LEGAL OFFICER -
Xia Ding,
Director